The price trend for C4 Therapeutics, Inc. (CCCC) has been bearish lately and the stock has lost 7% over the past week. However, the formation of a hammer chart pattern in its last trading session ...

C4 Therapeutics, Inc. (CCCC) has been beaten down lately with too much selling pressure. While the stock has lost 21.9% over the past four weeks, there is light at the end of the tunnel as it is now ...

The average one-year price target for C4 Therapeutics (NasdaqGS:CCCC) has been revised to $10.05 / share. This is a decrease of 13.75% from the prior estimate of $11.66 dated January 11, 2026. The ...

As of September 13, 2025, the average one-year price target for C4 Therapeutics is $14.79/share. The forecasts range from a low of $3.03 to a high of $52.50. The average price target represents an ...

Chinese state-owned engineering giant China Communications Construction Company (CCCC) will counter growing uncertainty in the growth of its overseas projects, some of which has been caused by US ...

Investing.com -- Moody’s Ratings has confirmed the Baa1 issuer rating and ba1 Baseline Credit Assessment (BCA) for China Communications Construction Co., Ltd. (CCCC). The ratings for the subordinated ...

A downtrend has been apparent in C4 Therapeutics, Inc. (CCCC) lately with too much selling pressure. The stock has declined 23.1% over the past four weeks. However, given the fact that it is now in ...